Search Results - Mu-Sheng Zeng
- Showing 1 - 20 results of 32
- Go to Next Page
-
1
-
2
-
3
-
4
EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation. by Xiaoting Xu, Nannan Zhu, Junming Zheng, Yingying Peng, Mu-Sheng Zeng, Kai Deng, Chaohui Duan, Yan Yuan
Published in PLoS Pathogens (2024-01-01)Get full text
Article -
5
-
6
Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma. by Zi-Chen Zhang, Yang-Yang Li, Hai-Yun Wang, Sha Fu, Xiao-Pai Wang, Mu-Sheng Zeng, Yi-Xin Zeng, Jian-Yong Shao
Published in PLoS ONE (2014-01-01)Get full text
Article -
7
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus by Ling Zhong, Claude Krummenacher, Wanlin Zhang, Junping Hong, Qisheng Feng, Qinjian Zhao, Yixin Chen, Mu-Sheng Zeng, Yi-Xin Zeng, Miao Xu, Xiao Zhang
Published in Virology Journal (2022-11-01)Get full text
Article -
8
Structure and Antigenicity of Kaposi's Sarcoma‐Associated Herpesvirus Glycoprotein B by Xin‐Yan Fang, Cong Sun, Chu Xie, Bing‐Zhen Cheng, Zheng‐Zhou Lu, Ge‐Xin Zhao, Sen‐Fang Sui, Mu‐Sheng Zeng, Zheng Liu
Published in Advanced Science (2025-07-01)Get full text
Article -
9
Urgency and necessity of Epstein-Barr virus prophylactic vaccines by Ling Zhong, Claude Krummenacher, Wanlin Zhang, Junping Hong, Qisheng Feng, Yixin Chen, Qinjian Zhao, Mu-Sheng Zeng, Yi-Xin Zeng, Miao Xu, Xiao Zhang
Published in npj Vaccines (2022-12-01)Get full text
Article -
10
PD-1+CXCR5−CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma by Shu-Mei Yan, Jiang-Ping Li, Chang-You Wu, Ming-Yuan Chen, Shang-Xin Liu, Yin-Feng Kang, Cong Sun, Jennifer R Grandis, Mu-Sheng Zeng, Qian Zhong
Published in Journal for ImmunoTherapy of Cancer (2021-07-01)Get full text
Article -
11
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants by Yin-Feng Kang, Cong Sun, Jing Sun, Chu Xie, Zhen Zhuang, Hui-Qin Xu, Zheng Liu, Yi-Hao Liu, Sui Peng, Run-Yu Yuan, Jin-Cun Zhao, Mu-Sheng Zeng
Published in Nature Communications (2022-05-01)Get full text
Article -
12
Multiple TMA-aided CRISPR/Cas13a platform for highly sensitive detection of IL-15 to predict immunotherapeutic response in nasopharyngeal carcinoma by Yu Wang, Qi Huang, Wan-Li Liu, Meng Wu, Xiao-hui Li, Mu-Sheng Zeng, Ya-Xian Wu, Shan Xing, Bo-Yu Tian, Xue-Ping Wang, Xia He, Shu-Lin Chen
Published in Journal for ImmunoTherapy of Cancer (2023-08-01)Get full text
Article -
13
Super-enhancer driven SOX2 promotes tumor formation by chromatin re-organization in nasopharyngeal carcinomaResearch in context by Shang-Xin Liu, Chong Wang, Ruo-Bin Lin, Wei-Yue Ding, Gaurab Roy, Hong-Bo Wang, Ting Yang, Qian Liu, Yi-Ling Luo, Shui-Lin Jin, Mu-Sheng Zeng, Bo Zhao, Qian Zhong
Published in EBioMedicine (2023-12-01)Get full text
Article -
14
mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice by Ge‐Xin Zhao, Guo‐Long Bu, Gang‐Feng Liu, Xiang‐Wei Kong, Cong Sun, Zi‐Qian Li, Dan‐Ling Dai, Hai‐Xia Sun, Yin‐Feng Kang, Guo‐Kai Feng, Qian Zhong, Mu‐Sheng Zeng
Published in Advanced Science (2023-12-01)Get full text
Article -
15
Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes by Qian Wu, Ling Zhong, Dongmei Wei, Wanlin Zhang, Junping Hong, Yinfeng Kang, Kaiyun Chen, Yang Huang, Qingbing Zheng, Miao Xu, Mu-Sheng Zeng, Yi-Xin Zeng, Ningshao Xia, Qinjian Zhao, Claude Krummenacher, Yixin Chen, Xiao Zhang
Published in Emerging Microbes and Infections (2023-12-01)Get full text
Article -
16
Comparison of long-term survival and toxicity of cisplatin delivered weekly versus every three weeks concurrently with intensity-modulated radiotherapy in nasopharyngeal carcinoma. by Chang-Juan Tao, Li Lin, Guan-Qun Zhou, Ling-Long Tang, Lei Chen, Yan-Ping Mao, Mu-Sheng Zeng, Tie-Bang Kang, Wei-Hua Jia, Jian-Yong Shao, Hai-Qiang Mai, Ai-Hua Lin, Jun Ma, Ying Sun
Published in PLoS ONE (2014-01-01)Get full text
Article -
17
Human herpesvirus 6B glycoprotein B postfusion structure, vulnerability mapping, and receptor recognition. by Chu Xie, Xin-Yan Fang, Yuan-Tao Liu, Xian-Shu Tian, Lan-Yi Zhong, Pei-Huang Wu, Hang Zhou, Peng-Lin Li, Yan-Lin Yang, Zi-Ying Jiang, Sen-Fang Sui, Zheng Liu, Mu-Sheng Zeng, Cong Sun
Published in PLoS Pathogens (2025-07-01)Get full text
Article -
18
Human herpesvirus 6B glycoprotein B postfusion structure, vulnerability mapping, and receptor recognition by Chu Xie, Xin-Yan Fang, Yuan-Tao Liu, Xian-Shu Tian, Lan-Yi Zhong, Pei-Huang Wu, Hang Zhou, Peng-Lin Li, Yan-Lin Yang, Zi-Ying Jiang, Sen-Fang Sui, Zheng Liu, Mu-Sheng Zeng, Cong Sun
Published in PLoS Pathogens (2025-07-01)Get full text
Article -
19
Targeted Therapy of Central Nervous System Acute Lymphoblastic Leukemia with an Integrin α6-Targeted Self-Assembling Proapoptotic Nanopeptide by Jia-Cong Ye, Wan-Qiong Li, Mei-Ling Chen, Qian-Kun Shi, Hua Wang, Xin-Ling Li, Ying-He Li, Jie Yang, Qiao-Li Wang, Fang Hu, Yan-Feng Gao, Shu-Wen Liu, Mu-Sheng Zeng, Guo-Kai Feng
Published in Engineering (2024-04-01)Get full text
Article -
20
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection by Ling Zhong, Wanlin Zhang, Hong Liu, Xinyu Zhang, Zeyu Yang, Zhenfu Wen, Ling Chen, Haolin Chen, Yanran Luo, Yanhong Chen, Qisheng Feng, Mu-Sheng Zeng, Qinjian Zhao, Lixin Liu, Claude Krummenacher, Yi-Xin Zeng, Yongming Chen, Miao Xu, Xiao Zhang
Published in Nature Communications (2024-06-01)Get full text
Article
